Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Geoffrey M. Dusheiko

Peginterferon Alfa-2a in Patients With Chronic Hepatitis C and Cirrhosis

New England Journal of Medicine

Medicine

2000

English

Hepatitis B Virus Infection and Hepatocellular Carcinoma: Correlation Between IgM Antibody to Hepatitis B Core Antigen, Hepatitis B E Antigen, and Hepatitis B DNA

American Journal of Tropical Medicine and Hygiene

English

Related publications

PGI18 Treatment of Chronic Hepatitis C Patients With Peginterferon Alfa-2a or Peginterferon Alfa-2b: A Cost-Effectiveness Analysis for the Portuguese NHS Setting

English

Cost-Effectiveness Analysis of Treatment With Peginterferon-Alfa-2a Versus Peginterferon-Alfa-2b for Patients With Chronic Hepatitis C Under the Public Payer Perspective in Brazil

Cost Effectiveness and Resource Allocation

Health Policy

2013

English

Virological Response to Treatment With Peginterferon Alfa-2a in Adolescents With Chronic Hepatitis B.

Acta Biochimica Polonica

English

Peginterferon Alfa-2b and Ribavirin Therapy in Kuwaiti Patients With Chronic Hepatitis C Virus Infection

Eastern Mediterranean Health Journal

Medicine

2011

English

Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C

English

Peginterferon Alfa-2a Is Associated With Elevations in Alanine Aminotransferase at the End of Treatment in Chronic Hepatitis C Patients With Sustained Virologic Response

PLoS ONE

Multidisciplinary

2014

English

Efficacy and Safety of Peginterferon Alfa-2a (40KD) in Children With Chronic Hepatitis B: The PEG-B-ACTIVE Study

English

Impact of Pegylated Interferon-Alfa-2a on Perforin Level in Patients With Chronic Hepatitis B; Preliminary Study

English

Serum Hepatitis B Virus RNA Levels as a Predictor of HBeAg Seroconversion During Treatment With Peginterferon Alfa-2a

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Geoffrey M. Dusheiko

Peginterferon Alfa-2a in Patients With Chronic Hepatitis C and Cirrhosis

Hepatitis B Virus Infection and Hepatocellular Carcinoma: Correlation Between IgM Antibody to Hepatitis B Core Antigen, Hepatitis B E Antigen, and Hepatitis B DNA

Related publications

PGI18 Treatment of Chronic Hepatitis C Patients With Peginterferon Alfa-2a or Peginterferon Alfa-2b: A Cost-Effectiveness Analysis for the Portuguese NHS Setting

Cost-Effectiveness Analysis of Treatment With Peginterferon-Alfa-2a Versus Peginterferon-Alfa-2b for Patients With Chronic Hepatitis C Under the Public Payer Perspective in Brazil

Virological Response to Treatment With Peginterferon Alfa-2a in Adolescents With Chronic Hepatitis B.

Peginterferon Alfa-2b and Ribavirin Therapy in Kuwaiti Patients With Chronic Hepatitis C Virus Infection

Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C

Peginterferon Alfa-2a Is Associated With Elevations in Alanine Aminotransferase at the End of Treatment in Chronic Hepatitis C Patients With Sustained Virologic Response

Efficacy and Safety of Peginterferon Alfa-2a (40KD) in Children With Chronic Hepatitis B: The PEG-B-ACTIVE Study

Impact of Pegylated Interferon-Alfa-2a on Perforin Level in Patients With Chronic Hepatitis B; Preliminary Study

Serum Hepatitis B Virus RNA Levels as a Predictor of HBeAg Seroconversion During Treatment With Peginterferon Alfa-2a